Nexplanon 68 MG implants
Ended Awarded Last action
- Contract number
- SPE2DR26FJNZ4
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,572
Award facts
- Contract value 100% obligated
- $12,571.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $12,571.95 to DMS Pharmaceutical Group Inc. on January 20, 2026, for the supply of Nexplanon 68 mg implants. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is scheduled for ultimate completion on February 10, 2026, with firm fixed-price terms, and represents a routine pharmaceutical supply requirement for Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs for military healthcare facilities worldwide. The parent IDC, designated SPE2DR and awarded in November 2025 with a $499.999 billion ceiling value through December 31, 2036, authorizes DLA to issue delivery orders for a comprehensive range of pharmaceuticals and medical consumables. DMS Pharmaceutical Group's established performance across numerous prior delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FJNZ4?
SPE2DR26FJNZ4 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FJNZ4 worth?
The government has obligated $12,572 on SPE2DR26FJNZ4.
Is contract SPE2DR26FJNZ4 an order under another contract?
Yes. SPE2DR26FJNZ4 is a delivery order under SPE2DR25D9226, an indefinite delivery contract.
Was contract SPE2DR26FJNZ4 competed?
The extent of competition for SPE2DR26FJNZ4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award